Antimicrobial stewardship and Clostridium difficile-associated diarrhea

Journal of Pharmacy Practice

Volumn 26, Issue 5, 2013, Pages 506-513

  Piacenti, Frank J ^a   Leuthner, Kimberly D ^b  

^a LINCOLN MEDICAL AND MENTAL HEALTH CENTER   (United States)

^b University Medical Center of Southern Nevada   (United States)

Author keywords

antibiotic usage; antimicrobial stewardship; Clostridium difficile

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; BACTERIAL FLORA; CLOSTRIDIUM DIFFICILE INFECTION; COMPUTERIZED PROVIDER ORDER ENTRY; ELECTRONIC MEDICAL RECORD; FEEDBACK SYSTEM; HEALTH CARE COST; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; KIDNEY FUNCTION; LENGTH OF STAY; MEDICAL AUDIT; POLICY; PRACTICE GUIDELINE; PRESCRIPTION; PUBLIC HEALTH PROBLEM; STAFF TRAINING; TREATMENT DURATION;

ANTIBIOTIC USAGE; ANTIMICROBIAL STEWARDSHIP; CLOSTRIDIUM DIFFICILE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; DRUG MONITORING; DRUG RESISTANCE, BACTERIAL; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84884696511     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190013499528     Document Type: Article

References (26)

1. McDonald LC, Lessa F, Sievert D, et al. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012 ; 61 (9). 157-162
2. Colemen RW, Rodondi LC, Kaubisch S, et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med. 1991 ; 90 (4). 439-444
3. Fraser GL, Stogsdill P, Dickens JD, et al. Antibiotic optimization. Arch Intern Med. 1997 ; 157 (15). 1689-1694
4. Kaki R, Elligsen M, Walker S, et al. Impact of antimicrobial stewardship in critical care: a systemic review. J Antimicrob Chemother. 2011 ; 66 (6). 1223-1230
5. Linares LA, Thornton DJ, Strymish J, et al. Electronic memorandum decreases unnecessary antimicrobial use for asymptomatic bacteriuria and culture-negative pyuria. Infect Control Hosp Epidemiol. 2011 ; 32 (7). 644-648
6. Hecker MT, Aron DC, Patel NP, et al. Unnecessary use of antimicrobials in hospitalized patients. Arch intern Med. 2003 ; 163 (8). 972-978
7. Owens RC, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ; 46 (suppl 1). S19 - S31
8. Dellit TH, Owens RC, McGowan JE, et al. Infectious disease society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Inf Dis. 2007 ; 44 (2). 159-177
9. Septimus EJ, Owens RC. Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis. 2011 ; 53 (suppl 1). S8 - S14
10. Abbo L, Sinkowitz-Cochran R, Smith L, et al. Faculty and resident physicians' attitudes, perceptions, and knowledge about antimicrobial use and resistance. Infect Control Hosp Epidemiol. 2011 ; 32 (7). 714-718
11. Srinivasan A, Song X, Richards A, et al. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch Intern Med. 2004 ; 164 (13). 1451-1456
12. Giblin TB, Sinkowitz-Cochran RL, Harris PL, et al. Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities. Arch Intern Med. 2004 ; 164 (15). 1662-1668
13. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother. 2012 ; 67 (12). 2988-2996
14. Elligsen M, Walker SA, Pinto R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol. 2012 ; 33 (4). 354-361
15. Yam P, Fales D, Jemison J, et al. Implementation of an antimicrobial stewardship program in a rural hospital. Am J Health Syst Pharm. 2012 ; 69 (13). 1142-1148
16. Kallen AJ, Thompson A, Ristaino P, et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect control Hosp Epidemiol. 2009 ; 30 (3). 264-272
17. Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis. 2007 ; 45 (10). 1266-1273
18. Talpaert MJ, Rao GG, Cooper BS, et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011 ; 66 (9). 2168-2174
19. Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007 ; 45 (suppl 2). S112 - S121
20. Fowler A, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother. 2007 ; 59 (5). 990-995
21. Cook PP, Rizzo S, Gooch M, et al. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. J Antimicrob Chemother. 2011 ; 66 (1). 205-209
22. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011 ; 52 (suppl 1). S23 - S28
23. Leuthner KD, Greenberg A. Chicago, IL: ; 2011 :
24. Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003 ; 24 (9). 699-706
25. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005 ; 41 (9). 1254-1260
26. Weiss K, Boisvert A, Chagnon M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009 ; 30 (2). 156-162